Champions Oncology, Inc. Stock Analysis & AI Score
Champions Oncology, Inc. (CSBR) has an ST Score of 42.6 (C), driven by its Profitability (A) and held back by its Growth (F). Analysts rate it Buy with a $12.00 price target (+142.4% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Champions Oncology, Inc. (CSBR) has an ST Score of 42.6 (C), driven by its Profitability (A) and held back by its Growth (F). Analysts rate it Buy with a $12.00 price target (+142.4% upside).
- Strongest
- ProfitabilityA
- Weakest
- GrowthF
All factor grades
- ProfitabilityA
- ForecastA
- ValuationC+
- SentimentC+
- MomentumC-
- Financial StrengthF
- GrowthF
- Piotroski3/9
Contact
CSBR stock: frequently asked questions
What is CSBR's ST Score?
Champions Oncology, Inc. (CSBR) has an ST Score of 42.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CSBR a buy, hold, or sell?
Analysts rate CSBR a Buy, with a price target of $12.00 (+142.4% vs the current price). Our ST Score grades it C (42.6/100). The ST Score is a data-driven signal, not a recommendation.
What are CSBR's factor grades?
Valuation C+, Profitability A, Financial Strength F, Momentum C-, Growth F, Forecast A, Sentiment C+.
What is CSBR's valuation grade?
Champions Oncology, Inc. (CSBR) earns a valuation grade of C+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CSBR's growth grade?
Champions Oncology, Inc. (CSBR) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CSBR's profitability grade?
Champions Oncology, Inc. (CSBR) earns a profitability grade of A, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CSBR's financial strength grade?
Champions Oncology, Inc. (CSBR) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CSBR?
The average analyst price target for Champions Oncology, Inc. (CSBR) is $12.00 from 7 analysts, which is +142.4% versus the recent price of $4.95.
What is CSBR's Piotroski score?
Champions Oncology, Inc. (CSBR) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.